YIELD10 BIOSCIENCE INC (YTEN) Stock Price, Quote, News and Overview
NASDAQ:YTEN - Nasdaq - US98585K8541 - Common Stock - Currency: USD
YTEN Quote, Performance and Key Statistics
2.88
-2.38 (-45.25%)
The current stock price of YTEN is 2.88 USD. In the past month the price decreased by -56.91%. In the past year, price decreased by -96.01%.
YTEN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About YTEN
Company Profile
Yield10 Bioscience, Inc. is an agricultural bioscience company, which engages in the development of oilseed Camelina sativa as a platform crop for large scale production of low carbon sustainable seed products. The company is headquartered in Woburn, Massachusetts and currently employs 30 full-time employees. The company went IPO on 2006-11-10. The firm is using its differentiated trait gene discovery platform, the TraitFactory, to develop improved Camelina varieties for the production of seed products, and to discover high value genetic traits for the agriculture and food industries. The seed products include Camelina oil for use as a low carbon biofuel feedstock, Omega-3 oils for nutrition and PHA Bioplastics for biodegradable zero-waste packaging solutions. The company is developing the oilseed Camelina sativa (Camelina) as a platform crop for large scale production of low carbon sustainable seed products to address petroleum replacement markets, food and nutrition markets, and animal feed markets. The company is engaged in the development of elite Camelina germplasm exhibiting herbicide tolerance, disease resistance and other traits. The firm's development pipeline falls into three categories: input traits, performance traits and new seed product traits.
Company Info
YIELD10 BIOSCIENCE INC
19 Presidential Way Ste 201
Woburn MASSACHUSETTS 01801 US
CEO: Oliver P. Peoples
Employees: 30
Company Website: https://www.yield10bio.com/
Phone: 16175831700
YIELD10 BIOSCIENCE INC / YTEN FAQ
What is the stock price of YIELD10 BIOSCIENCE INC today?
The current stock price of YTEN is 2.88 USD. The price decreased by -45.25% in the last trading session.
What is the ticker symbol for YIELD10 BIOSCIENCE INC stock?
The exchange symbol of YIELD10 BIOSCIENCE INC is YTEN and it is listed on the Nasdaq exchange.
On which exchange is YTEN stock listed?
YTEN stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for YIELD10 BIOSCIENCE INC stock?
7 analysts have analysed YTEN and the average price target is 12.24 USD. This implies a price increase of 325% is expected in the next year compared to the current price of 2.88. Check the YIELD10 BIOSCIENCE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is YIELD10 BIOSCIENCE INC worth?
YIELD10 BIOSCIENCE INC (YTEN) has a market capitalization of 44.35M USD. This makes YTEN a Nano Cap stock.
How many employees does YIELD10 BIOSCIENCE INC have?
YIELD10 BIOSCIENCE INC (YTEN) currently has 30 employees.
What are the support and resistance levels for YIELD10 BIOSCIENCE INC (YTEN) stock?
YIELD10 BIOSCIENCE INC (YTEN) has a resistance level at 5.65. Check the full technical report for a detailed analysis of YTEN support and resistance levels.
Is YIELD10 BIOSCIENCE INC (YTEN) expected to grow?
The Revenue of YIELD10 BIOSCIENCE INC (YTEN) is expected to grow by 2712.5% in the next year. Check the estimates tab for more information on the YTEN EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy YIELD10 BIOSCIENCE INC (YTEN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of YTEN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of YTEN, evaluating the profitability, health, valuation and growth aspects
- YIELD10 BIOSCIENCE INC (YTEN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- YIELD10 BIOSCIENCE INC (YTEN) Sales and EPS estimates to see what analysts future expectations are.
- YIELD10 BIOSCIENCE INC (YTEN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- YIELD10 BIOSCIENCE INC (YTEN) Insider and Institutional Ownership to learn about the owners and their transactions.
- YIELD10 BIOSCIENCE INC (YTEN) Stock Chart to make your own analysis
- YIELD10 BIOSCIENCE INC (YTEN) Latest news and press-releases to stay up to date.
Does YIELD10 BIOSCIENCE INC (YTEN) stock pay dividends?
YTEN does not pay a dividend.
When does YIELD10 BIOSCIENCE INC (YTEN) report earnings?
YIELD10 BIOSCIENCE INC (YTEN) will report earnings on 2024-08-12, after the market close.
What is the Price/Earnings (PE) ratio of YIELD10 BIOSCIENCE INC (YTEN)?
YIELD10 BIOSCIENCE INC (YTEN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-32.44).
YTEN Technical Analysis
YTEN Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to YTEN. Both the profitability and financial health of YTEN have multiple concerns.
YTEN Financial Highlights
Over the last trailing twelve months YTEN reported a non-GAAP Earnings per Share(EPS) of -32.44. The EPS decreased by -1075.36% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -370% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
YTEN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 46% to YTEN. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 97.63% and a revenue growth 2712.5% for YTEN